AmeriCann, Inc. on November 2, 2015, appointed Dr. Rien Havens to the company's Advisory Board to assist in the areas of extraction, laboratory design, and infused product development. Dr. Havens specializes in plant medicine and product development, with almost a decade of experience designing extraction systems, end products, conducting product and process research and creating innovative strategies for the cannabis industry. Dr. Havens has created new, patent pending extraction technologies, and has developed product lines for health and wellness industries.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0599 USD | +4.08% | +34.91% | -29.53% |
1st Jan change | Capi. | |
---|---|---|
-29.53% | 1.4M | |
+22.22% | 261M | |
-9.28% | 211M | |
+25.58% | 167M | |
+43.09% | 130M | |
+300.00% | 121M | |
-56.54% | 103M | |
-28.57% | 96.6M | |
+71.19% | 96.17M | |
-23.08% | 66.82M |
- Stock Market
- Equities
- ACAN Stock
- News AmeriCann, Inc.
- AmeriCann, Inc. Appoints Rien Havens to the Advisory Board